LEVOTHYROXINE

Course overview

ORAL LEVOTHYROXINE IS PRIMARILY INDICATED FOR THE TREATMENT OF PRIMARY, SECONDARY, AND TERTIARY HYPOTHYROIDISM. PRIMARY HYPOTHYROIDISM IS WHEN THE PROBLEM OCCURS IN THE THYROID GLAND. SECONDARY HYPOTHYROIDISM IS WHEN THE PROBLEM IS IN THE PITUITARY GLAND, AND THERE IS A DECREASE IN THE PRODUCTION OF THYROID-STIMULATING HORMONE (TSH). TERTIARY HYPOTHYROIDISM IS VERY RARE. THIS ACTIVITY COVERS LEVOTHYROXINE, INCLUDING MECHANISM OF ACTION, PHARMACOLOGY, ADVERSE EVENT PROFILES, ELIGIBLE PATIENT POPULATIONS, MONITORING, AND HIGHLIGHTS THE ROLE OF THE INTERPROFESSIONAL TEAM IN THE MANAGEMENT OF VARIOUS FORMS OF HYPOTHYROIDISM WITH LEVOTHYROXINE.